AUNA PROVIDES UPDATE ON CAPITAL STRUCTURE INITIATIVES
LUXEMBOURG CITY, Luxembourg, Oct. 25, 2023 /PRNewswire/ -- Auna S.A. ("Auna" or the "Company") intends to confidentially submit a draft registration statement on Form F-1 to the U.S. Securities and Exchange Commission (the "SEC") for a proposed initial public offering of Auna's Class A shares in the U.S. The Company is contemplating consummating the proposed initial public offering sometime in 2024, but both the offering itself and the timing thereof are subject to market conditions, other considerations, and the completion of the SEC's review process.
The underlying decision to raise equity capital in the international capital markets is a part of Auna's broader strategy to strengthen its capital base, extend its debt maturities and continue its expansion in Spanish Speaking Latin America.
This press release is not an offer to sell, or the solicitation of an offer to buy, any securities. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the U.S. Securities Act of 1933 and other applicable securities laws.
Chemistree Technology Inc. and (US OTC: CHMJF) (the "Company" or "Chemistree"), announces that its board of directors (the "Board") has approved a restructuring transaction (the "Restructuring Transaction"), pursuant to which all of the principal of...
United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, will unveil its latest MRI technology, boasting incredible advancements across various fronts, as a Gold sponsor at this year's ISMRM meeting.
The...
In the news release, Mitsubishi Tanabe Pharma America to Present RADICAVA ORS® (edaravone) Real-World Data at the Professional Society for Health Economics and Outcomes Research 2024 Annual Meeting, issued 03-May-2024 by Mitsubishi Tanabe Pharma...
Affiliated Dermatologists (AD) is providing notice of a recent data security incident. At this time, AD is not aware of any misuse of any personal information in connection with this incident.
What Happened?
On March 5, 2024, AD detected it was the...
With recent news of dairy cattle in the United States testing positive for the Highly Pathogenic Avian Influenza (HPAI) and reports of fragments of HPAI detected in pasteurized milk sold in the U.S., we understand that Canadians may be concerned...
Butterfly Medical Ltd, an early-stage medical device company focused on alleviating suffering in patients with BPH (Benign Prostatic Hyperplasia), is excited to announce the hiring of Patrick MacCarthy as CEO. ...
